Enveric Biosciences Faces Delisting Concerns

Ticker: ENVB · Form: 8-K · Filed: Oct 23, 2025 · CIK: 890821

Enveric Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyEnveric Biosciences, Inc. (ENVB)
Form Type8-K
Filed DateOct 23, 2025
Risk Levelhigh
Pages7
Reading Time8 min
Key Dollar Amounts$0.01, $2.5 million, $3.00, $0.915, $2.2 million
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-rule-violation, compliance

Related Tickers: ENVB

TL;DR

ENVB might get kicked off Nasdaq - big trouble ahead.

AI Summary

Enveric Biosciences, Inc. filed an 8-K on October 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's stock was previously traded on the Nasdaq Capital Market under the ticker symbol "ENVB". This filing indicates potential issues with maintaining its listing on the exchange.

Why It Matters

This filing signals potential financial distress or non-compliance with exchange rules, which could significantly impact the stock's liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing a significant risk to its operations and shareholder value.

Key Players & Entities

  • Enveric Biosciences, Inc. (company) — Registrant
  • Nasdaq Capital Market (company) — Exchange where stock was listed
  • ENVB (company) — Stock ticker symbol

FAQ

What specific rule or standard has Enveric Biosciences failed to satisfy for continued listing on the Nasdaq Capital Market?

The filing does not specify the exact rule or standard that Enveric Biosciences has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is October 22, 2025.

What is Enveric Biosciences' state of incorporation?

Enveric Biosciences, Inc. is incorporated in Delaware.

What is the SEC file number for Enveric Biosciences?

The SEC file number for Enveric Biosciences is 001-38286.

What was Enveric Biosciences' former company name?

Enveric Biosciences, Inc. was formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC.

Filing Stats: 1,968 words · 8 min read · ~7 pages · Grade level 12.7 · Accepted 2025-10-23 16:30:50

Key Financial Figures

  • $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
  • $2.5 million — inimum required stockholders' equity of $2.5 million as stipulated by Nasdaq Listing Rule 55
  • $3.00 — bruary 3, 2025, at an exercise price of $3.00 per share (collectively, the "Existing
  • $0.915 — Warrants at a reduced exercise price of $0.915 per share in consideration for the Comp
  • $2.2 million — gregate gross proceeds of approximately $2.2 million from the exercise of the Existing Warra
  • $1.00 — Company's Common Stock had fallen below $1.00 per share for 30 consecutive trading da

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 23, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.